|
⚲
|
| Keyboard |
| EMBL Ventures Verwaltungs GmbH
✚
|
|
|---|---|
| CIK # | 0001722603 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001722603] | |
| 4 | [0001722603] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| EMBL Technology Fund II GmbH & Co KG | |
| Muhlenbeck Frank | |
| X4 Pharmaceuticals Inc | |
| Herr Stefan | |
| Adams Jan | |
| EMBL Ventures Verwaltungs GmbH |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Buy | 20,000 | $10.00 | 200,000 |
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 247,176 | ||
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 103,278 | ||
|
X4 Pharmaceuticals Inc ASNS
Series D Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 843,613 | $0.00 | |
|
X4 Pharmaceuticals Inc ASNS
Series C Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 207,253 | $0.00 |